Kempharm Inc (NQ: KMPH )
9.810
USD
+1.100
(+12.63%)
Streaming Delayed Price
Updated: 2:23 PM EST, Feb 26, 2021
Add to My Watchlist
Press releases about Kempharm Inc
Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences?
February 16, 2021
From PR Newswire
InvestorNewsBreaks – KemPharm Inc. (NASDAQ: KMPH) Secures $52.4M in Follow-on and $44M in Warrant Exchange Transaction
February 12, 2021
From InvestorBrandNetwork
KemPharm Announces 1-for-16 Reverse Stock Split
December 23, 2020
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
December 22, 2020
KemPharm Participates in KP415 Late-Cycle Communication Meeting with FDA
December 02, 2020
KemPharm Provides Update on Development Pipeline
November 23, 2020
KemPharm Reports Third Quarter 2020 Financial Results
October 29, 2020
KemPharm Files Preliminary Proxy for Special Meeting of Stockholders
September 25, 2020
KemPharm to Present at Upcoming September Investor Conferences
September 02, 2020
KemPharm Reports Second Quarter 2020 Financial Results
August 12, 2020
KemPharm to Report Second Quarter 2020 Financial Results
August 04, 2020
KemPharm Issues Letter to Shareholders
June 18, 2020
KemPharm Receives Day-74 Letter for KP415 NDA
May 19, 2020
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.